CMS Issues Hospital IPPS Proposed Rule for FY 2027

Why It Matters

The rule reshapes hospital revenue streams, rewarding EHR‑enabled facilities but tightening margins for safety‑net providers, while the mandatory CJR‑X expansion accelerates the shift toward value‑based care across the acute‑care sector.

Key Takeaways

• CMS proposes 2.4% Medicare IPPS increase, adding $1.9 B in FY 2027
• Market basket rise of 3.2% offset by 0.8% productivity cut
• Disproportionate share payments drop $564 M amid rising uninsured rates
• New CJR-X model would be mandatory for most acute‑care hospitals
• AHA urges phased, voluntary rollout to protect smaller hospitals

Pulse Analysis

The FY 2027 IPPS proposal marks the most sizable Medicare payment adjustment in recent years, injecting an estimated $1.9 billion into hospital revenues. While the 3.2% market‑basket increase reflects broader inflationary pressures, the 0.8% productivity reduction tempers growth, especially for facilities that do not meet the meaningful‑use EHR criteria. Simultaneously, CMS trims $564 million from disproportionate‑share and uncompensated‑care subsidies, a move that could strain safety‑net hospitals as the uninsured rate climbs toward 9.1%. The added $464 million for new medical‑technology payments and a potential $400 million boost for low‑volume hospitals aim to balance innovation incentives with financial sustainability.

A centerpiece of the proposal is the nationwide rollout of the Comprehensive Care for Joint Replacement model, rebranded CJR‑X, slated for October 1, 2027. The program will hold all acute‑care hospitals—except those in the Transforming Episode Accountability Model or located in Maryland—accountable for total episode costs and quality outcomes through 90 days post‑discharge. By mandating participation, CMS seeks to standardize value‑based incentives for lower‑extremity joint replacements, a high‑volume, high‑cost service line. Critics, including the American Hospital Association, warn that a one‑size‑fits‑all mandate could overwhelm smaller or financially constrained hospitals that lack the infrastructure for rapid care redesign.

Beyond payment rates, the rule bundles extensive quality‑reporting and residency reforms. CMS proposes new electronic clinical quality measures, removes outdated eCQMs, and expands Medicare Advantage inclusion in several condition‑specific metrics. Adjustments to the Hospital Value‑Based Purchasing and Readmissions Reduction programs aim to tighten outcome tracking, while clarifications on residency program discrimination and organ‑acquisition policies address compliance gaps. Stakeholders have until June 9, 2026, to comment, underscoring the high‑stakes policy window for hospitals navigating evolving Medicare incentives and regulatory expectations.